When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Neurological diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis, pose a significant global health challenge due to their complex pathogenesis and widespread ...

Murray, T. J. (2004). Multiple sclerosis: the history of a disease. Demos Medical Publishing. National Institute of Allergy and Infectious Diseases. National Institutes of Health Website.

TG Therapeutics sees growth from BRIUMVI’s MS launch, but competition, pipeline risks, and valuation concerns limit upside.

Researchers from several institutions in Brazil developed an enhanced protocol for extracting and analyzing proteins from human skin, combining chemical and mechanical lysis, SP3 sample preparation, ...

Ihuoma Eneli, MD, MS, discusses early intervention in childhood obesity to reduce long‑term risk and supporting families with ...

Autoimmune diseases, especially in women, are associated with nearly a twofold increased risk for affective disorders, new ...

Recognizing the difference between normal aging and early cognitive decline is crucial for timely intervention. Subtle ...

Patients Demonstrate Significant Knowledge Gaps in Treatment Options, Leading to Lost Hope and Treatment Discontinuation Over ...

In support of World Vitiligo Day, a new survey sheds light on emotional and social challenges faced by patients and their families.

Mount Sinai has received a transformative $5 million gift from Clifford S. Asness, PhD, and Laurel Asness to advance research and clinical care for ...

Birmingham has a very strong history of immunology research going back 30 years, and with one of the greatest concentrations of scientists and doctors in the world is well positioned to make a ...